Related Experiment Video

Updated: Jun 22, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

[Fungal infections in the neonate - diagnosis, treatment and prevention]

Dorota Pawlik1, Ryszard Lauterbach

  • 1Klinika Neonatologii Uniwersytetu Jagiellońskiego Collegium Medicum, 31-501 Kraków.

Medycyna Wieku Rozwojowego
|May 28, 2009
PubMed

Insights

This study offers guidelines for diagnosing and treating fungal infections in premature infants. It also suggests prophylaxis strategies, including fluconazole schedules, based on clinical data.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Context:

  • Fungal infections pose a significant threat to prematurely delivered infants, particularly those with very low birth weight.
  • Existing data on diagnosis, treatment, and prophylaxis are fragmented and require synthesis.
  • Clinical experience and recent research underscore the need for standardized management protocols.

Purpose:

  • To present and discuss current data on fungal infections in premature infants.
  • To propose evidence-based guidelines for the diagnosis and treatment of these infections.
  • To suggest a rationale and schedule for antifungal prophylaxis in high-risk neonates.

Summary:

  • The authors synthesized findings from meta-analyses, randomized controlled trials, and clinical experience to develop diagnostic and treatment guidelines for fungal infections in premature infants.
  • A rationale for antifungal prophylaxis in very low birth weight infants is presented.
  • A fluconazole prophylaxis schedule, informed by ten years of clinical observation, is proposed.

Impact:

  • Provides clinicians with updated, evidence-based guidelines for managing fungal infections in vulnerable premature infants.
  • Aims to reduce the incidence and severity of fungal infections in neonatal intensive care units.
  • Contributes to improved outcomes and survival rates for extremely preterm infants susceptible to invasive fungal disease.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...